Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	$ (7,158)	$ (193)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	202	178
Share-based compensation expense	191	146
Impairment charge	3,577	0
Gain on sale of equipment	(6)	0
Changes in operating assets and liabilities:
Accounts receivable	1,268	964
Inventory	(1,659)	(1,222)
Accounts payable	1,097	2
Accrued advertising and other allowances	319	(67)
Other operating assets and liabilities, net	691	473
Net cash provided by (used in) operating activities	(1,478)	281
Cash flows from investing activities:
Capital expenditures	(122)	(324)
Proceeds from the sale of equipment	6	0
Net cash used in investing activities	(116)	(324)
Cash flows from financing activities:
Proceeds from the exercise of stock options	0	27
Proceeds from issuance of common stock	4,909	195
Net cash provided by financing activities	4,909	222
Net increase in cash and cash equivalents	3,315	179
Cash and cash equivalents at beginning of period	1,638	572
Cash and cash equivalents at end of period	4,953	751
Supplemental disclosure of cash flow information:
Treasury stock acquired pursuant to a settlement agreement	$ 5,105	$ 0